WGSWW · Insider Trading
GeneDx Holdings Corp. Warrant
Every open-market purchase and sale reported by WGSWW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +3,468 | −$226.60K |
| 2026-06-18 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +8,249 | −$638.10K |
| 2026-06-11 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +2,907 | −$195.67K |
| 2026-06-11 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +1,196 | −$68.07K |
| 2026-06-08 | Casdin Capital, LLC | Director | Buy | +800,000 | +$44.44M |
| 2026-06-03 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +348 | −$19.09K |
| 2026-05-20 | Casdin Partners GP, LLC | Director | Buy | +2,000,000 | +$85.84M |
| 2026-05-15 | Corvex Management LP | Director | Buy | +702,546 | +$27.53M |
| 2026-05-11 | Casdin Capital, LLC | Director | Buy | +3,400,000 deriv. | — |
| 2026-05-11 | Corvex Management LP | Director | Buy | +2,410,294 | +$93.61M |
| 2026-05-01 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +362 | −$25.56K |
| 2026-05-01 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +1,702 | −$141.59K |
| 2026-03-30 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +7,432 | −$557.05K |
| 2026-03-30 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +33,067 | −$2.96M |
| 2026-03-17 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +5,306 | −$438.20K |
| 2026-03-17 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +13,492 | −$1.32M |
| 2026-03-11 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +1,182 | −$111.05K |
| 2026-03-11 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +2,868 | −$319.06K |
| 2026-03-09 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | A | +3,404 | +$299.93K |
| 2026-03-09 | Kevin Feeley | CHIEF FINANCIAL OFFICER | A | +1,986 | +$174.99K |
| 2026-03-05 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +9,075 | −$486.37K |
| 2026-03-05 | Bryan Dechairo | Chief Operating Officer | A | +10,430 deriv. | — |
| 2026-03-05 | Keith A. Meister | Director | Buy | +339,042 | +$26.92M |
| 2026-03-05 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +22,225 | −$2.00M |
| 2026-03-03 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +431 | −$22.25K |
| 2026-02-06 | Bryan Dechairo | Chief Operating Officer | Sell | −5,961 | −$510.87K |
| 2026-02-03 | Bryan Dechairo | Chief Operating Officer | MIXED | +5,961 | −$339.68K |
| 2026-02-02 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +437 | −$29.79K |
| 2026-02-02 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +2,221 | −$155.37K |
| 2025-12-18 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +7,893 | −$1.56M |
| 2025-12-18 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +3,342 | −$554.62K |
| 2025-12-11 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +2,908 | −$579.62K |
| 2025-12-11 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +1,196 | −$201.65K |
| 2025-12-03 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +340 | −$61.28K |
| 2025-11-26 | Joshua Ruch | Director | Sell | −38,000 | −$6.09M |
| 2025-10-31 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +365 | −$52.98K |
| 2025-10-31 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +1,716 | −$294.65K |
| 2025-10-06 | Corvex Management LP | 10%+ Owner | — | — | — |
| 2025-10-01 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | −5,363 | −$675.55K |
| 2025-10-01 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | Sell | −12,858 | −$1.39M |
| 2025-09-19 | Thomas Fuchs | Director | A | −3,438 deriv. | — |
| 2025-09-18 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | −10,925 | −$452.85K |
| 2025-09-18 | Kevin Feeley | CHIEF FINANCIAL OFFICER | M | +7,197 | — |
| 2025-09-18 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | MIXED | +8,249 | −$1.28M |
| 2025-09-11 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +1,190 | −$162.89K |
| 2025-09-11 | Katherine Stueland | Chief Executive Officer | MIXED | +2,889 | −$468.30K |
| 2025-09-03 | Kevin Feeley | CHIEF FINANCIAL OFFICER | MIXED | +339 | −$47.56K |
| 2025-08-27 | Jason Ryan | Director | Sell | −39,222 | −$5.00M |
| 2025-08-22 | Eli Casdin | Director | Sell | −2,000,000 | −$241.81M |
| 2025-08-07 | Eli Casdin | Director | M | +12,924 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Corvex Management LP | Director | 4,785,834 | $957 |
| Casdin Partners GP, LLC | Director | 3,202,681 | $641 |
| Keith A. Meister | Director | 3,158,151 | $632 |
| Eli Casdin | Director | 3,027,682 | $606 |
| School Of Medicine At Mount Sinai Icahn | 10%+ Owner | 2,719,692 | $544 |
| Jason Ryan | Director | 135,473 | $27 |
| Katherine Stueland | CHIEF EXECUTIVE OFFICER | 112,733 | $23 |
| Joshua Ruch | Director | 56,381 | $11 |
| Kevin Feeley | CHIEF FINANCIAL OFFICER | 43,683 | $9 |
| Richard C Pfenniger Jr | Director | 41,506 | $8 |
| Casdin Capital, LLC | Director | 39,764 | $8 |
| Emily M. Leproust | Director | 21,276 | $4 |
| Bryan Dechairo | Chief Operating Officer | 2,100 | $0 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the WGSWW quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.